The Sports & Active Nutrition Summit returns in 2022 as a in person event. This unique opportunity will bring scientists, formulators, consultants and regulatory experts together in a venue overlooking Mission Bay in San Diego.
Glanbia plc are to sell its 40% interest in Glanbia Ireland to Glanbia Co-op in a deal worth €307m as the group looks to focus on its nutrition-based business interests that tap into consumer health and wellness.
Spreading the claims butter too thin and not investing in science can kill any category, even a popular one with durable demand, an astaxanthin supplier claims.
French ingredients supplier Nexira is to acquire UNIPEKTIN Ingredients in a deal that taps into the firm’s diversification strategy, which places boosted health and nutrition activity front-and-centre of its plans.
Tests on omega-3 marine oils used in dietary supplements has revealed one product exceeded concentration limits of harmful pollutants such as dioxins and dioxin-like polychlorinated biphenyls (PCBs).
IFF Health has made a series of podcasts and virtual educational summits available as part of a new microbiome resource that provides the latest industry insights into the sector.
In addition to benefits for focus and athletic performance, without any of the negative effects of caffeine, Ingenious Ingredients’ new paraxanthine ingredient is being felt by consumers "in a way that they’ve never felt caffeine".
With established science for nausea and digestive and emerging data supporting a potential impact on the gut microbiota (and therefore immunity), the market opportunity for ginger ingredients continues to grow.
Global food ingredients giant ADM announced today it will acquire Deerland Probiotics & Enzymes, significantly expanding its capacity in microbiome-targeted ingredients.
AkerBiomarine is to enter the world of esports, lining up with Norwegian team Heroic in an agreement that sees the Norwegian biotech firm providing krill oil-based omega-3 supplements.
The unprecedented growth of elderberry demand carries with it a potential poison pill if dilution produces enough ineffective products that consumer confidence is lost, one supplier maintains.
